329 related articles for article (PubMed ID: 23324593)
21. A deadly spread: cellular mechanisms of α-synuclein transfer.
Steiner JA; Angot E; Brundin P
Cell Death Differ; 2011 Sep; 18(9):1425-33. PubMed ID: 21566660
[TBL] [Abstract][Full Text] [Related]
22. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
[TBL] [Abstract][Full Text] [Related]
23. Early Forms of
Flønes IH; Nyland H; Sandnes DA; Alves GW; Tysnes OB; Tzoulis C
Biomolecules; 2022 May; 12(6):. PubMed ID: 35740871
[TBL] [Abstract][Full Text] [Related]
24. Alpha-synuclein, lipids and Parkinson's disease.
Ruipérez V; Darios F; Davletov B
Prog Lipid Res; 2010 Oct; 49(4):420-8. PubMed ID: 20580911
[TBL] [Abstract][Full Text] [Related]
25. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.
Surmeier DJ; Guzman JN; Sanchez-Padilla J
Cell Calcium; 2010 Feb; 47(2):175-82. PubMed ID: 20053445
[TBL] [Abstract][Full Text] [Related]
26. α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.
Wang R; Sun H; Ren H; Wang G
Sci China Life Sci; 2020 Dec; 63(12):1850-1859. PubMed ID: 32681494
[TBL] [Abstract][Full Text] [Related]
27. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
28. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
29. The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.
Hastings TG
J Bioenerg Biomembr; 2009 Dec; 41(6):469-72. PubMed ID: 19967436
[TBL] [Abstract][Full Text] [Related]
30. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
31. The origins of oxidant stress in Parkinson's disease and therapeutic strategies.
Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
Antioxid Redox Signal; 2011 Apr; 14(7):1289-301. PubMed ID: 20712409
[TBL] [Abstract][Full Text] [Related]
32. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.
Miraglia F; Betti L; Palego L; Giannaccini G
Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035
[TBL] [Abstract][Full Text] [Related]
33. Initiation and propagation of α-synuclein aggregation in the nervous system.
Hijaz BA; Volpicelli-Daley LA
Mol Neurodegener; 2020 Mar; 15(1):19. PubMed ID: 32143659
[TBL] [Abstract][Full Text] [Related]
34. Fas-associated factor 1 and Parkinson's disease.
Betarbet R; Anderson LR; Gearing M; Hodges TR; Fritz JJ; Lah JJ; Levey AI
Neurobiol Dis; 2008 Sep; 31(3):309-15. PubMed ID: 18573343
[TBL] [Abstract][Full Text] [Related]
35. α-Synuclein Propagation Mouse Models of Parkinson's Disease.
Uemura N; Ueda J; Okuda S; Sawamura M; Takahashi R
Methods Mol Biol; 2021; 2322():119-130. PubMed ID: 34043198
[TBL] [Abstract][Full Text] [Related]
36. Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta.
Eriksen N; Stark AK; Pakkenberg B
J Neural Transm Suppl; 2009; (73):203-13. PubMed ID: 20411779
[TBL] [Abstract][Full Text] [Related]
37. Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease.
He Y; Yu Z; Chen S
ACS Chem Neurosci; 2019 Feb; 10(2):777-782. PubMed ID: 30183251
[TBL] [Abstract][Full Text] [Related]
38. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
[TBL] [Abstract][Full Text] [Related]
39. Modulation of alpha-synuclein aggregation by dopamine: a review.
Leong SL; Cappai R; Barnham KJ; Pham CL
Neurochem Res; 2009 Oct; 34(10):1838-46. PubMed ID: 19444607
[TBL] [Abstract][Full Text] [Related]
40. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions.
Stoyka LE; Arrant AE; Thrasher DR; Russell DL; Freire J; Mahoney CL; Narayanan A; Dib AG; Standaert DG; Volpicelli-Daley LA
Neurobiol Dis; 2020 Feb; 134():104708. PubMed ID: 31837424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]